The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample

Journal of Psychopharmacology

Volumn 28, Issue 8, 2014, Pages 780-788

  Lawn, Will ^a   Barratt, Monica ^b   Williams, Martin ^c   Horne, Abi ^d   Winstock, Adam ^e,f,g  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CURTIN UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF SUSSEX   (United Kingdom)

^e SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g Global Drug Survey   (United Kingdom)

Author keywords

Demographics; hallucinogen; internet drug market; legal drugs; n bomb; NBOMe; oral drugs; psychedelic; psychoactive drugs; public health; recreational drugs; risk behaviour; survey

Indexed keywords

25B NBOME; 25C NBOME; 25I NBOME; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4' METHYLMETHCATHINONE; CANNABIS; COCAINE; KETAMINE; METHYLONE; PSYCHEDELIC AGENT; SEROTONIN AGONIST; UNCLASSIFIED DRUG; PHENETHYLAMINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; DEMOGRAPHY; DRUG USE; FEMALE; HISTORY; HUMAN; INTERNET; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SELF REPORT; UNITED KINGDOM; UNITED STATES; VERY ELDERLY; CROSS-SECTIONAL STUDY; HEALTH SURVEY; INTERNATIONAL COOPERATION; MIDDLE AGED; PSYCHOLOGY; SELF MEDICATION; STATISTICS AND NUMERICAL DATA; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DRUG USERS; FEMALE; HALLUCINOGENS; HEALTH SURVEYS; HUMANS; INTERNATIONALITY; INTERNET; MALE; MIDDLE AGED; PHENETHYLAMINES; SELF MEDICATION; SELF REPORT; YOUNG ADULT;

EID: 84904622758     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881114523866     Document Type: Article

References (33)

1. Braden MR, Parrish JC, Naylor JC, et al. Molecular interaction of serotonin 5-Ht2a receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Mol Pharmacol. 2006 ; 70: 1956-1964
2. Caldicott DG, Bright SJ, Barratt MJ. Nbome: A very different kettle of fish. Med J Aust. 2013 ; 199: 322-323
3. Drugs-Forum (2013) Spanish batch alert: 25i-Nbome blotters sold as LSD. Available at: www.drugs-forum.con/forum/showthrewad.php?t=204870 (accessed 17 May 2013).
4. Erowid (2011a) Nbome series. Available at: http://erowid.org/chemicals/ nbome (accessed 17 May 2013).
5. Erowid (2011b) Nbome series reports. Available at: http://erowid.org/ experiences/subs/exp-NBOMe-Series.shtml (accessed 17 May 2013).
6. Erowid (2011c) Nbome series dose. Available at: http://erowid.org/ chemicals/nbome/nbome-dose.shtml (accessed 17 May 2013).
7. Erowid (2012a) 25i-Nbome legal status Available at: http://erowid.org/ chemicals/2ci-nbome/2ci-nbome-law.shtml (accessed 1 November 2013).
8. Erowid (2012b) 25i-Nbome (2c-I-Nbome) Fatalities/deaths. Available at: http://erowid.org/chemicals/2ci-nbome-death.shtml (accessed 17 May 2013).
9. Ettrup A, Hansen M, Santini MA, et al. Radiosynthesis and in vivo evaluation of a series of substituted 11c-phenethylamines as 5-Ht (2a) agonist pet tracers. Eur J Nucl Med Molec Imag. 2011 ; 38: 681-693
10. Fiorella D, Helsley S, Lorrain DS, et al. The role of the 5-Ht2a and 5-Ht2c receptors in the stimulus effects of hallucinogenic drugs. The mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion. Psychopharmacology. 1995 ; 121: 364-372
11. Freeman TP, Morgan CJ, Vaughn-Jones J, et al. Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'. Addiction. 2012 ; 107: 792-800
12. Geyer MA, Vollenweider FX. Serotonin research: Contributions to understanding psychoses. Trends Pharmacol Sci. 2008 ; 29: 445-453
13. Halberstadt AL, Geyer MA. Effects of the hallucinogen 2, 5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology. 2014 ; 77: 200-207
14. Hill SL, Doris T, Gurung S, et al. Severe clinical toxicity associated with analytically confirmed recreational use of 25i-Nbome: Case series. Clin Toxicol. 2013 ; 51: 487-492
15. Home Office (2013) 'Nbome' and 'Benzofury' banned. Available at: www.gov.uk/government/news/nbome-and-benzofry-to-be-banned (accessed 1 November 2013).
16. McCambridge J, Winstock A, Hunt N, et al. 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. Eur Addiction Res. 2007 ; 13: 57-64
17. Marek GJ, Aghajanian GK. LSD and the phenethylamine hallucinogen Doi are potent partial agonists at 5-Ht2a receptors on interneurons in rat piriform cortex. J Pharmacol Exp Ther. 1996 ; 278: 1373-1382
18. Miron JA, Zwiebel J. The economic case against drug prohibition. The Journal of Economic Perspectives. 1995 ; 9: 175-192
19. Morgan CJ, Curran HV. Ketamine use: A review. Addiction. 2012 ; 107: 27-38
20. Morgenstern J, Langenbucher J, Labouvie EW. The generalizability of the dependence syndrome across substances: An examination of some properties of the proposed DSM-IV Dependence Criteria. Addiction. 1994 ; 89: 1105-1113
21. Nichols DE. Hallucinogens. Pharmacol Ther. 2004 ; 101: 131-181
22. Ninnemann A, Stuart GL. The NBOMe series: A novel, dangerous group of hallucinogenic drugs. J Studies Alcohol Drugs. 2013 ; 74: 977
23. Passie T, Halpern JH, Stichtenoth DO, et al. The pharmacology of lysergic acid diethylamide: A review. CNS Neurosci Therapeut. 2008 ; 14: 295-314
24. RalstonNDaviesL (2013) Teen jumps to his death after $1.50 drug hit. Sydney Morning Herald (6June2013). Available at: www.smh.com.au/nsw/teen- jumps-to-his-death-after-150-drug-hit-20130606-2nrpe.html (accessed 1 August 2013).
25. Rose SR, Poklis JL, Poklis A. A case of 25i-Nbome (25-I) intoxication: A new potent 5-Ht2a agonist designer drug. Clin Toxicol. 2013 ; 51: 174-177
26. Stellpflug SJ, Kealey SE, Hegarty CB, et al. 2-(4-Iodo-2, 5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl] ethanamine (25I-NBOMe): Clinical case with unique confirmatory testing. J Med Toxicol. 2013 ;: 1-6
27. Winstock A, Mitcheson L, Marsden J. Mephedrone: Still available and twice the price. Addiction. 2010 ; 376: 1
28. Winstock AR, Barratt MJ. Synthetic Cannabis: A comparison of patterns of use and effect profile with natural Cannabis in a large global sample. Drug Alcohol Depend. 2013 ; 131: 106-111
29. Winstock AR, Griffiths P, Stewart D. Drugs and the dance music scene: A survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug Alcohol Depend. 2001 ; 64: 9-17
30. Winstock AR, Kaar S, Borschmann R. Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample. J Psychopharmacol. 2013 ; 28: 49-54
31. Winstock AR, Mitcheson LR, Deluca P, et al. Mephedrone, new kid for the chop?. Addiction. 2011 ; 106: 154-161
32. Zuba D, Sekula K. Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2c-Series of phenethylamine drugs. Drug Test Analysis. 2012 ; 5: 634-645
33. Zuba D, Sekula K, Buczek A. 25c-Nbome: New potent hallucinogenic substance identified on the drug market. Forensic Sci Int. 2013 ; 227: 7-14